These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2801984)

  • 1. Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans.
    Smitherman TC; Popma JJ; Said SI; Krejs GJ; Dehmer GJ
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1254-62. PubMed ID: 2801984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
    Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
    J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
    Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
    Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide.
    Popma JJ; Smitherman TC; Bedotto JB; Eichhorn EJ; Said SI; Dehmer GJ
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):1000-6. PubMed ID: 1704974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H601-7. PubMed ID: 2843056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
    Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracoronary infusion of the vasoactive intestinal peptide antagonist [4Cl-D-Phe6-Leu17]VIP in the awake dog.
    Quebbemann BB; Rivier J; Bache RJ
    Peptides; 1991; 12(5):989-93. PubMed ID: 1800959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of lidocaine on systemic and coronary hemodynamics.
    Thomsen JH; Terry W; Stenlund RR; Querimit S; Rowe GG
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of vaso-active intestinal polypeptide on systemic and splanchnic haemodynamics: role in vasodilation following mesenteric ischaemia.
    Somjen G; Fletcher DR; Shulkes A; Hardy KJ
    Digestion; 1988; 40(3):133-43. PubMed ID: 3234619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.
    Nandiwada PA; Kadowitz PJ; Said SI; Mojarad M; Hyman AL
    J Appl Physiol (1985); 1985 May; 58(5):1723-8. PubMed ID: 3997734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
    Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
    Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and coronary hemodynamic effects of sodium nitroprusside.
    Rowe GG; Henderson RH
    Am Heart J; 1974 Jan; 87(1):83-7. PubMed ID: 4808762
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary and systemic haemodynamic effects of prostaglandins in the unanaesthetized dog.
    Bloor CM; White FC; Sobel BE
    Cardiovasc Res; 1973 Mar; 7(2):156-66. PubMed ID: 4694100
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):365-71. PubMed ID: 2464111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous vasoactive intestinal polypeptide lowers pulmonary-to-systemic vascular resistance ratio in a neonatal piglet model of pulmonary arterial hypertension.
    Haydar S; Sarti JF; Grisoni ER
    J Pediatr Surg; 2007 May; 42(5):758-64. PubMed ID: 17502178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat.
    Minkes RK; McMahon TJ; Hood JS; Murphy WA; Coy DH; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1992 Mar; 72(3):1212-7. PubMed ID: 1568976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circulatory effects of epinephrine infusion in the anesthesized piglet.
    Barrington K; Chan W
    Pediatr Res; 1993 Feb; 33(2):190-4. PubMed ID: 8433894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
    Ismailov ShI; Flerov EV
    Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasoactive intestinal peptide on myocardial performance.
    Xenopoulos NP; Applegate RJ
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H399-405. PubMed ID: 8141340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.